 |
| Tuberculosis |
According to the 2016 WHO report, in 2015, there were an
estimated 10.4 million new TB cases worldwide, 1.0 million (10%) of them were
children. People living with HIV accounted for 1.2 million (11%) of all new TB
cases. More alarmingly, multidrug-resistant tuberculosis (MDR TB) and
extensively drug resistant tuberculosis (XDR TB) cases are on the rise. In
2015, 3.9% of new and 21% of previously treated TB cases were estimated to have
been caused by MDR-TB. Read More>>>>>>
Throughout
the history of medicine, complementary and alternative medicine (CAM) has
played a significant role in the treatment of cancer patients. In 1999, the
National Institutes of Health (NIH) created the National Center for
Complementary and Alternative Medicine (NCCAM) in recognition of this growing
field. Research funding to the NCCAM has risen from $ 2 million in 1992 to $50
million by 2000 and is expected to be more than $110 million by the mid-2000’.
A survey conducted in 2005 indicated that approximately 35.9% of cancer
patients attempted use of CAM during their treatment course. In fact, that
percentage may be even higher as studies have shown that many patients do not
disclose the use of CAM therapy unless asked specifically. Physicians poorly
communicate with their patients regarding the potential benefits or harms of
CAM because they have minimal understanding of CAM therapy and its
physiological role in managing diseases. Patients are often dissatisfied with
their physicians’ lack of knowledge regarding CAM therapy. Patients who have a
history of incorporating CAM into their management plan are generally driven by
personal beliefs and principles regarding life and health. Read more>>>>>>>>>>>>>
